2016 Hematological Malignancies

163 / 1835

How to further improve DLBCL
• Refractory
– Use new drugs
– Subgroup of patients with high risk
• Relapse
– Higher dose chemotherapy
– Prevent relapse
• At time of relapse
– Better salvage regimens